|
1
|
Plate KH, Scholz A and Dumont DJ: Tumor
angiogenesis and anti-angiogenic therapy in malignant gliomas
revisited. Acta Neuropathol. 124:763–775. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ping YF and Bian XW: Concise review:
Contribution of cancer stem cells to neovascularization. Stem
Cells. 29:888–894. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El Hallani S, Boisselier B, Peglion F,
Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL,
Eichmann A, et al: A new alternative mechanism in glioblastoma
vascularization: Tubular vasculogenic mimicry. Brain. 133:973–982.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong J, Zhao Y, Huang Q, Fei X, Diao Y,
Shen Y, Xiao H, Zhang T, Lan Q and Gu X: Glioma stem/progenitor
cells contribute to neovascularization via transdifferentiation.
Stem Cell Rev. 7:141–152. 2011. View Article : Google Scholar
|
|
7
|
Zhao Y, Dong J, Huang Q, Lou M, Wang A and
Lan Q: Endothelial cell transdifferentiation of human glioma stem
progenitor cells in vitro. Brain Res Bull. 82:308–312. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ricci-Vitiani L, Pallini R, Biffoni M,
Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G,
Larocca LM, et al: Tumour vascularization via endothelial
differentiation of glioblastoma stem-like cells. Nature.
468:824–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang R, Chadalavada K, Wilshire J, Kowalik
U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C and
Tabar V: Glioblastoma stem-like cells give rise to tumour
endothelium. Nature. 468:829–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong IS, Lee HY and Kang KS: Mesenchymal
stem cells and cancer: Friends or enemies? Mutat Res. 768:98–106.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong J, Zhang Q, Huang Q, Chen H, Shen Y,
Fei X, Zhang T, Diao Y, Wu Z, Qin Z, et al: Glioma stem cells
involved in tumor tissue remodeling in a xenograft model. J
Neurosurg. 113:249–260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang Q, Zhang QB, Dong J, Wu YY, Shen YT,
Zhao YD, Zhu YD, Diao Y, Wang AD and Lan Q: Glioma stem cells are
more aggressive in recurrent tumors with malignant progression than
in the primary tumor, and both can be maintained long-term in
vitro. BMC Cancer. 8:3042008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong J, Dai XL, Lu ZH, Fei XF, Chen H,
Zhang QB, Zhao YD, Wang ZM, Wang AD, Lan Q, et al: Incubation and
application of transgenic green fluorescent nude mice in
visualization studies on glioma tissue remodeling. Chin Med J.
125:4349–4354. 2012.PubMed/NCBI
|
|
14
|
Wu Z, Huang Q, Shao YX, Xue ZM, Dong J,
Diao Y, Wang AD and Lan Q: Transplantation of human glioma stem
cells in nude mice with green fluorescent protein expression.
Zhonghua Yi Xue Za Zhi. 88:2317–2320. 2008.In Chinese. PubMed/NCBI
|
|
15
|
Liu H, Toh WS, Lu K, MacAry PA, Kemeny DM
and Cao T: A subpopulation of mesenchymal stromal cells with high
osteogenic potential. J Cell Mol Med. 13:2436–2447. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng L, Huang Z, Zhou W, Wu Q, Donnola S,
Liu JK, Fang X, Sloan AE, Mao Y, Lathia JD, et al: Glioblastoma
stem cells generate vascular pericytes to support vessel function
and tumor growth. Cell. 153:139–152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu AY and Ouyang G: Tumor angiogenesis: A
new source of pericytes. Curr Biol. 23:R565–R568. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Silva GV, Litovsky S, Assad JA, Sousa AL,
Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, et al:
Mesenchymal stem cells differentiate into an endothelial phenotype,
enhance vascular density, and improve heart function in a canine
chronic ischemia model. Circulation. 111:150–156. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Janeczek Portalska K, Leferink A, Groen N,
Fernandes H, Moroni L, van Blitterswijk C and de Boer J:
Endothelial differentiation of mesenchymal stromal cells. PloS One.
7:e468422012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang WH, Chang MC, Tsai KS, Hung MC, Chen
HL and Hung SC: Mesenchymal stem cells promote growth and
angiogenesis of tumors in mice. Oncogene. 32:4343–4354. 2013.
View Article : Google Scholar
|
|
21
|
Beckermann BM, Kallifatidis G, Groth A,
Frommhold D, Apel A, Mattern J, Salnikov AV, Moldenhauer G, Wagner
W, Diehlmann A, et al: VEGF expression by mesenchymal stem cells
contributes to angiogenesis in pancreatic carcinoma. Br J Cancer.
99:622–631. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ho IA, Toh HC, Ng WH, Teo YL, Guo CM, Hui
KM and Lam PY: Human bone marrow-derived mesenchymal stem cells
suppress human glioma growth through inhibition of angiogenesis.
Stem Cells. 31:146–155. 2013. View Article : Google Scholar
|
|
23
|
Kim SM, Kang SG, Park NR, Mok HS, Huh YM,
Lee SJ, Jeun SS, Hong YK, Park CK and Lang FF: Presence of glioma
stroma mesenchymal stem cells in a murine orthotopic glioma model.
Childs Nerv Syst. 27:911–922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim YG, Jeon S, Sin GY, Shim JK, Kim BK,
Shin HJ, Lee JH, Huh YM, Lee SJ, Kim EH, et al: Existence of glioma
stroma mesenchymal stemlike cells in Korean glioma specimens.
Childs Nerv Syst. 29:549–563. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schichor C, Albrecht V, Korte B, Buchner
A, Riesenberg R, Mysliwietz J, Paron I, Motaln H, Turnšek TL,
Jürchott K, et al: Mesenchymal stem cells and glioma cells form a
structural as well as a functional syncytium in vitro. Exp Neurol.
234:208–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop D and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tropel P, Noël D, Platet N, Legrand P,
Benabid AL and Berger F: Isolation and characterisation of
mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res.
295:395–406. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dallas NA, Samuel S, Xia L, Fan F, Gray
MJ, Lim SJ and Ellis LM: Endoglin (CD105): A marker of tumor
vasculature and potential target for therapy. Clin Cancer Res.
14:1931–1937. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bjerkvig R, Tysnes BB, Aboody KS, Najbauer
J and Terzis A: Opinion: The origin of the cancer stem cell:
Current controversies and new insights. Nat Rev Cancer. 5:899–904.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dittmar T, Nagler C, Schwitalla S, Reith
G, Niggemann B and Zänker KS: Recurrence cancer stem cells - made
by cell fusion? Med Hypotheses. 73:542–547. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu X and Kang Y: Cell fusion as a hidden
force in tumor progression. Cancer Res. 69:8536–8539. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu X and Kang Y: Cell fusion hypothesis of
the cancer stem cell. Cell Fusion in health and Disease. Springer;
pp. 129–140. 2011, View Article : Google Scholar
|
|
33
|
Quintana-Bustamante O, Alvarez-Barrientos
A, Kofman AV, Fabregat I, Bueren JA, Theise ND and Segovia JC:
Hematopoietic mobilization in mice increases the presence of bone
marrow-derived hepatocytes via in vivo cell fusion. Hepatology.
43:108–116. 2006. View Article : Google Scholar
|
|
34
|
Suzuki K, Sun R, Origuchi M, Kanehira M,
Takahata T, Itoh J, Umezawa A, Kijima H, Fukuda S and Saijo Y:
Mesenchymal stromal cells promote tumor growth through the
enhancement of neovascularization. Mol Med. 17:579–587. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shinojima N, Hossain A, Takezaki T, Fueyo
J, Gumin J, Gao F, Nwajei F, Marini FC, Andreeff M, Kuratsu J, et
al: TGF-β mediates homing of bone marrow-derived human mesenchymal
stem cells to glioma stem cells. Cancer Res. 73:2333–2344. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fonsatti E, Nicolay HJ, Altomonte M, Covre
A and Maio M: Targeting cancer vasculature via endoglin/CD105: A
novel antibody-based diagnostic and therapeutic strategy in solid
tumours. Cardiovasc Res. 86:12–19. 2010. View Article : Google Scholar
|
|
37
|
Warrington K, Hillarby MC, Li C, Letarte M
and Kumar S: Functional role of CD105 in TGF-beta1 signalling in
murine and human endothelial cells. Anticancer Res. 25:1851–1864.
2005.PubMed/NCBI
|
